LabCompass

Pengyue Zhang

Pharmacology, Toxicology and Pharmaceutics · Indiana University

OpenAlex ORCID
Pharmacovigilance and Adverse Drug ReactionsComputational Drug Discovery MethodsPharmaceutical Practices and Patient OutcomesAtrial Fibrillation Management and OutcomesAlzheimer's disease research and treatments

Publications

14

Citations

43

Est. group size

—

Recurring co-author estimate

Active years

11

Publishing since 2015

Research summary
AI-generated

Pengyue Zhang works in pharmacology and pharmaceutical research, with recent projects applying computational and artificial-intelligence methods to drug discovery and treatment strategies for Alzheimer's disease. Other work examines drug safety (monitoring adverse reactions) and the pharmacological properties of natural compounds. The research bridges data-driven analysis and traditional medicinal substances.

Drug safety and adverse-reaction monitoringAI and computational drug discoveryAlzheimer's disease treatment researchPharmaceutical practice and patient outcomesPharmacology of natural compounds

Publication activity has grown notably in recent years, rising from a single paper in 2023 to nine in 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.4/year recently
1718192021222023: 1 publication232024: 2 publications242025: 9 publications92526
Recent publications
Publishes in
  • Drug Safety×2
  • Alzheimer s & Dementia×1
  • The Journal of Prevention of Alzheimer s Disease×1
  • Statistics in Medicine×1
  • Scientific Reports×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile